AKT1 and colorectal carcinoma: Collectively, their findings demonstrated that miR-766-3p suppresses the phosphatidylinositol 3−kinase (PI3K)/protein kinase B (AKT) pathway by targeting the expression of HNF4G, which in turn limits the growth of CRC cells (111).